A detailed history of Group One Trading, L.P. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 321,655 shares of BLUE stock, worth $131,878. This represents 0.01% of its overall portfolio holdings.

Number of Shares
321,655
Previous 522,659 38.46%
Holding current value
$131,878
Previous $669,000 52.91%
% of portfolio
0.01%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.85 - $1.26 $170,853 - $253,265
-201,004 Reduced 38.46%
321,655 $315,000
Q1 2024

May 10, 2024

SELL
$0.91 - $1.75 $387,145 - $744,511
-425,435 Reduced 44.87%
522,659 $669,000
Q4 2023

Feb 14, 2024

BUY
$1.32 - $4.83 $374,051 - $1.37 Million
283,372 Added 42.63%
948,094 $1.31 Million
Q3 2023

Nov 09, 2023

SELL
$3.02 - $4.05 $396,317 - $531,485
-131,231 Reduced 16.49%
664,722 $2.02 Million
Q2 2023

Aug 09, 2023

BUY
$2.79 - $5.03 $1.77 Million - $3.19 Million
635,031 Added 394.62%
795,953 $2.62 Million
Q1 2023

May 12, 2023

BUY
$3.14 - $8.22 $505,295 - $1.32 Million
160,922 New
160,922 $511,000
Q3 2022

Nov 09, 2022

BUY
$3.75 - $7.39 $371,111 - $731,336
98,963 Added 169.04%
157,508 $997,000
Q2 2022

Aug 11, 2022

BUY
$2.94 - $5.23 $71,227 - $126,707
24,227 Added 70.6%
58,545 $242,000
Q1 2022

May 12, 2022

SELL
$4.07 - $10.6 $491,680 - $1.28 Million
-120,806 Reduced 77.88%
34,318 $166,000
Q4 2021

Feb 11, 2022

SELL
$8.96 - $16.31 $99,877 - $181,807
-11,147 Reduced 6.7%
155,124 $1.55 Million
Q3 2021

Nov 12, 2021

BUY
$11.24 - $21.0 $121,785 - $227,535
10,835 Added 6.97%
166,271 $3.18 Million
Q2 2021

Aug 10, 2021

SELL
$18.04 - $22.09 $564,904 - $691,726
-31,314 Reduced 16.77%
155,436 $4.97 Million
Q1 2021

May 12, 2021

BUY
$16.59 - $33.89 $1.76 Million - $3.6 Million
106,196 Added 131.83%
186,750 $5.63 Million
Q4 2020

Feb 10, 2021

BUY
$27.5 - $37.92 $1.62 Million - $2.24 Million
59,072 Added 274.98%
80,554 $3.49 Million
Q3 2020

Nov 12, 2020

SELL
$34.44 - $43.75 $280,513 - $356,343
-8,145 Reduced 27.49%
21,482 $1.16 Million
Q2 2020

Aug 13, 2020

SELL
$27.12 - $45.97 $1.12 Million - $1.91 Million
-41,452 Reduced 58.32%
29,627 $1.81 Million
Q1 2020

May 13, 2020

BUY
$26.16 - $63.5 $1.31 Million - $3.17 Million
49,967 Added 236.68%
71,079 $3.27 Million
Q4 2019

Feb 10, 2020

SELL
$46.96 - $61.67 $67,575 - $88,743
-1,439 Reduced 6.38%
21,112 $1.85 Million
Q3 2019

Nov 12, 2019

SELL
$59.47 - $93.1 $640,491 - $1 Million
-10,770 Reduced 32.32%
22,551 $2.07 Million
Q2 2019

Aug 09, 2019

BUY
$75.84 - $105.21 $2.14 Million - $2.97 Million
28,234 Added 555.02%
33,321 $4.24 Million
Q1 2019

May 13, 2019

SELL
$64.44 - $104.11 $1.75 Million - $2.83 Million
-27,228 Reduced 84.26%
5,087 $800,000
Q4 2018

Feb 06, 2019

SELL
$59.1 - $93.26 $1.04 Million - $1.64 Million
-17,553 Reduced 35.2%
32,315 $3.21 Million
Q3 2018

Nov 08, 2018

SELL
$88.86 - $117.49 $449,720 - $594,616
-5,061 Reduced 9.21%
49,868 $7.28 Million
Q2 2018

Aug 14, 2018

BUY
$99.64 - $127.59 $1.97 Million - $2.53 Million
19,801 Added 56.37%
54,929 $8.62 Million
Q1 2018

May 11, 2018

BUY
$105.8 - $150.94 $3.72 Million - $5.3 Million
35,128 New
35,128 $6 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $31.6M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.